Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innoviva Inc (INVA)
NASDAQ:INVA
Innoviva (INVA) Stock Price & Analysis
280 Followers
INVA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.22 - $18.56
Previous Close$18.19
Volume500.72K
Average Volume (3M)533.58K
Market Cap
$1.14B
Enterprise Value$1.40B
Total Cash (Recent Filing)$178.36M
Total Debt (Recent Filing)$446.76M
Price to Earnings (P/E)8.2
Beta0.50
Next Earnings
Oct 30, 2024EPS EstimateN/A
Last Dividend Ex-Date
Sep 08, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)2.23
Shares Outstanding62,444,778
10 Day Avg. Volume682,995
30 Day Avg. Volume533,583
Standard Deviation0.09
R-Squared0.11
Alpha-0.00079
Financial Highlights & Ratios
Price to Book (P/B)2.33
Price to Sales (P/S)11.57
Price to Cash Flow (P/CF)7.50
P/FCF Ratio6.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.79
Enterprise Value/Gross Profit5.24
Enterprise Value/Ebitda7.21
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
Innoviva News
PremiumCompany Announcements
Innoviva Updates Investor Presentation on Website
Ownership Overview
29.40% Insiders
33.13% Mutual Funds
37.24% Other Institutional Investors
0.24% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INVA FAQ
What was Innoviva Inc’s price range in the past 12 months?
Innoviva Inc lowest stock price was $12.22 and its highest was $18.56 in the past 12 months.
What is Innoviva Inc’s market cap?
Currently, no data Available
When is Innoviva Inc’s upcoming earnings report date?
Innoviva Inc’s upcoming earnings report date is Oct 30, 2024 which is in 95 days.
How were Innoviva Inc’s earnings last quarter?
Innoviva Inc released its earnings results on Jul 24, 2024. The company reported $0.235 earnings per share for the quarter, the consensus estimate of $0.235 by $0.
Is Innoviva Inc overvalued?
According to Wall Street analysts Innoviva Inc’s price is currently Overvalued.
Does Innoviva Inc pay dividends?
Innoviva Inc pays a Semiannually dividend of $0.25 which represents an annual dividend yield of N/A. See more information on Innoviva Inc dividends here
What is Innoviva Inc’s EPS estimate?
Innoviva Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innoviva Inc have?
Innoviva Inc has 62,444,780 shares outstanding.
What happened to Innoviva Inc’s price movement after its last earnings report?
Innoviva Inc reported an EPS of $0.235 in its last earnings report, expectations of $0.235. Following the earnings report the stock price went down -0.842%.
Which hedge fund is a major shareholder of Innoviva Inc?
Among the largest hedge funds holding Innoviva Inc’s share is Hussman Strategic Advisors Inc. It holds Innoviva Inc’s shares valued at 3M.
---
Innoviva Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
INVA Sentiment 80%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 77.4K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.32%
12-Months-Change
Fundamentals
Return on Equity
28.67%
Trailing 12-Months
Asset Growth
12.20%
Trailing 12-Months
Company Description
Innoviva Inc
Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
---
INVA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering INVA
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+5.90%
initiated a buy rating last month
Copying Louise Chen's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +5.90% per trade.
---